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Abstract— Many head-mounted virtual reality display 
(VR-HMD) applications that involve moving visual 
environments (e.g., virtual rollercoaster, car and airplane 
driving) will trigger cybersickness (CS). Previous 
research Arshad et al. (2015) has explored the inhibitory 
effect of cathodal transcranial direct current stimulation 
(tDCS) on vestibular cortical excitability, applied to 
traditional motion sickness (MS), however its 
applicability to CS, as typically experienced in immersive 
VR, remains unknown. The presented double-blinded 
2x2x3 mixed design experiment (independent variables: 
stimulation condition [cathodal/anodal]; timing of VR 
stimulus exposure [before/after tDCS]; sickness scenario 
[slight symptoms onset/moderate symptoms 
onset/recovery]) aims to investigate whether the tDCS 
protocol adapted from Arshad et al. (2015) is effective at 
delaying the onset of CS symptoms and/or accelerating 
recovery from them in healthy participants. Quantitative 
analysis revealed that the cathodal tDCS indeed delayed 
the onset of slight symptoms if compared to that in anodal 
condition. However, there are no significant differences in 
delaying the onset of moderate symptoms nor shortening 
time to recovery between the two stimulation types. 
Possible reasons for present findings are discussed and 
suggestions for future studies are proposed. 
Keywords—HMD-VR, vection, tDCS, inhibition of vestibular 
cortical excitability, mitigation of cybersickness. 
 
I. INTRODUCTION  
Virtual reality (VR) environments are designed using three 
technologies: non-immersive VR [1], semi-immersive VR [2] 
and immersive VR (IVR) [3]. There are two commonly used 
forms of IVR [3]: cave automatic virtual environments 
(CAVEs) and head-mounted displays (HMDs). A CAVE is a 
specially designed room in which the walls, ceiling, and/or 
floor are covered with a screen that can project virtual images 
or videos. An HMD is a VR headset that positions two small 
screens in front of both eyes, completely blocking out the 
physical world including the user’s body, and allows users to 
turn their head to examine their surroundings, with the visual 
presentation moving in the opposition direction of head 
motion with low latency [3]–[5]. Although a CAVE has many 
immersive qualities, the current state-of-the-art consumer-
friendly HMDs, including PC-powered HMDs (i.e., HTC 
Vive™), smartphone-based HMDs (i.e., Samsung Gear™), 
and all-in-one HMDs (i.e., Oculus Quest™), aim to achieve 
immersive effect in a manner that is both simple and 
inexpensive. 
A serious problem with VR-HMD is that users may 
develop symptoms similar to motion sickness (MS), a malady 
called pseudo motion sickness [4], visually-induced MS [5], 
or cybersickness (CS) [6]. This is unsurprising if the cause of 
CS can be explained by sensory conflict theory——a widely-
accepted theory regarding how MS occurs [7]. That is to say, 
a sensory mismatch between the vestibular and visual signals 
results in MS. In the case of VR-HMD, many applications that 
involve moving visual surroundings (e.g., virtual 
rollercoaster, car and airplane driving) may elicit an illusory 
feeling of self-motion, namely vection [8]. Once vection is not 
supported by corresponding vestibular information (that is, 
actual physical movement is absent), the visual-vestibular 
sensory conflict will trigger CS. Regarding the prevention or 
mitigation of CS, a direct solution is obviously to design a 
highly immersive VR that combines physical movement (e.g. 
typical consumer roomscale VR experiences), or utilizes 
locomotion techniques to avoid vection-inducing visual 
stimuli. However, such approaches are not always preferable, 
with physical movement requiring both effort and space, and 
locomotion techniques impacting immersion. Apart from the 
VR design itself, two types of indirect methods have been 
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proposed, in order to mitigate CS in a simple way: 1) 
adaptation training; 2) electrostimulation.  
Adaptation training requires users repeat the same VR 
experience over and over [9]. This kind of method is indeed 
simple, but quite time-consuming. More worryingly, it is 
likely that once an individual becomes habituated to the virtual 
world, they might be maladapted to the real world on VR 
cessation [10]. This phenomenon has something in common 
with a special case of MS, called ‘mal de debarquement', ‘land 
sickness' or ‘adaptive aftereffect' [7], [11]. One possible 
explanation is that a new orientation mechanism replaces the 
prior stored one with repeated exposure experience so that MS 
no longer occurs. However, once the newly established 
mechanism is facing reorientation, symptoms of MS occur 
once more, such as astronauts after returning to earth from a 
long trip in space [4].  
Electrostimulation is quite the opposite. This kind of 
method is, to some extent, just like motion sickness pills, 
which can mitigate symptoms with a faster effect than 
adaptation training [8], [12]. These electrostimulation 
methods are based on the hypothesis of dynamic multisensory 
reweighting. That is to say, our brain makes decisions by 
optimizing multisensory signals. In the context of CS, the 
weights of visual and vestibular signals can be adjusted 
(reweighted) based on the signal certainty and reliability [6]. 
The clearer and more reliable the input sensory signal is, the 
more weight it will be given (that is, up-weighting); on the 
contrary, less weight will be given when a cue isn’t reliable 
(that is, down-weighting). Obviously, the principles behind 
current electrostimulation approaches are to down-weight 
vestibular [8] and up-weight visual signals [12].  
Given that the vestibular system consists of vestibular 
sensory organs (e.g., otoliths and semi-circular canals) and 
vestibular cortices (e.g., parieto-insular vestibular cortex) 
[13], [14], there should be two ways to down-weight 
vestibular signals: 1) adding noise signals into vestibular 
sensory organs to affect the certainty of the sensory inputs; 2) 
inhibiting vestibular cortical excitability to affect the 
reliability of sensory inputs. However, currently, only the 
former has been studied, using galvanic vestibular stimulation 
(GVS) and bone-conducted vibration [8], [15]. It remains 
unknown whether inhibiting the vestibular cortical excitability 
could mitigate CS or not.  
Transcranial direct current stimulation (tDCS) is a non-
invasive electrical brain stimulation technique that modulates 
underlying cortical excitability [16]. Depending on whether 
anodal or cathodal stimulation is applied, tDCS increases or 
decreases cortical excitability, respectively [16]. The most 
prototypical brain region for showing increases and decreases 
in cortical excitability is motor cortex [17], [18]. However, for 
cognitive areas it is common to observe excitatory effects 
following anodal tDCS, but rarely to observe inhibitory effects 
following cathodal tDCS  [19]. Similarly, for vestibular areas, 
it is also common to observe anodal tDCS-induced effects 
(such as in temporoparietal junction (TPJ)) [12], [20], but 
rarely to find cathodal tDCS-based studies.  
Although a previous study, conducted by Arshad et. al., 
has shown encouraging results by using 1.5mA and 15-min 
cathodal tDCS at left parietal cortex [21], they focused on 
traditional off-axis vertical rotation (OAVR)-induced MS, 
rather than HMD-VR-induced CS. Note that the parietal 
cortex used here is believed to be part of the pure vestibular 
cortical area (PIVC), which is different from TPJ which is a 
visual-vestibular multisensory brain area related to body 
position and orientation. More details about the neural 
pathways of the vestibular cortical areas can be found in Frank 
and Greenlee’s review paper [14]. Therefore, the goal of this 
study was to replicate Arshad et. al.’ s tDCS solution [21] to 
assess its feasibility of mitigating CS. The significance of this 
study is twofold: 1) If Arshad et. al.’s approach [21] is able to 
mitigate CS, then it will lay the foundation of the development 
of combined sensory organ and cortex based multimodal 
neurostimulation for mitigation of CS; 2) If it does not work, 
then Arshad et. al.’s approach [21] might possibly be not 
strong enough to inhibit vestibular cortical activities, nor 
might inhibiting the vestibular cortex alone be enough to 
mitigate CS. Thus, future studies can be planned e.g. with 
further optimized tDCS parameters or advanced 
neuroimaging and neurostimulation technologies. 
 
II. METHODS AND MATERIALS 
A. Participants and Screening measures 
Potential participants were recruited through social media 
and the <redacted for review> subject pool. Exclusion criteria 
were abnormal vision, neurological disorders, contra-
indications of tDCS, and MS susceptibility questionnaire 
(MSSQ) score <10 or MSSQ score >36, or MSB score =0. 
Here, MSSQ score is a sum of total sickness score during 
childhood (<12 years of age, MSA) and during adulthood 
over the last 10 years (MSB) [22]. As the name implies, 
MSSQ is designed for MS. It is still unclear whether MSSQ 
is a good predictor for CS, although it has already been used 
in some VR studies [23]. Thus, the MSSQ and MSB 
thresholds shown above were specifically determined by our 
pilot studies, where a total of seventeen participants involved 
in either VR videos (including car driving, motorbike riding, 
and rollercoasters) or customized VR scenes (see Section 
tDCS and VR stimuli). For VR videos, we found that people 
who scored under 10 in the MSSQ were very unlikely to 
experience symptoms, therefore the MSSQ score screening 
criteria was set to a threshold between 10 and 36. Regarding 
the customized VR scenes, we found that giving more 
importance to the adult section of the MSSQ (that is MSB) 
could better select participants. This works under the 
assumption that adult susceptibility to MS is more recent and 
therefore more representative of the participants’ current state; 
this approach was adopted by Arshad et. al. [21]. Finally, 
twenty-three participants who successfully passed the 
screening criteria were recruited. Written informed consent 
was obtained from each participant according to procedures 
approved by the ethics panel of the University of Glasgow 
(No. 300160027), College of Science and Engineering. All 
participants were randomly assigned into either the cathodal 
(age=22.8, MSSQ= 15.97, MSB=6.7) or anodal (age= 20.3, 
MSSQ=19.48, MSB=8.99) groups. The data from three male 
participants had to be discarded as two of them did not reach 
the required moderate symptoms and another one admitted to 
not having understood the experiment instructions at the end 
of his session. The remaining twenty were ten males and ten 
females. Every participant was paid £6 per hour for taking 
part in the experiment. This study was carried out from March 
2018 to September 2019, which was before the Covid-19 
outbreak. 
B. Procedure 
Before the date of the experiment participants were given 
information and told what their participation would entail. 
They were instructed not to consume recreational drugs or 
more than 3 units of alcohol the day before the experiment, 
and coffee or any amount of alcohol the same day. At the time 
of their respective sessions, participants were taken to the 
room where the experiment would take place. Participants 
were first given the consent form, and once signed, an 
updated version of the tDCS safety questionnaire to make 
sure they met the safety conditions.  
The procedure for each group consisted of two test 
sessions: before and after the active tDCS, as shown in the 
two black rectangles in Figure 1A. Each session was 
structured as shown in Figure 1B. The tDCS was operated 
and the electrodes were fitted on participants’ heads by an 
experienced tDCS operator. The researcher leading the 
experiment did not know if each participant was experiencing 
cathodal or anodal stimulation, only the tDCS operator knew 
(double-blind design). After each stimulation, participants 
were given a questionnaire to make sure they were not able 
to differentiate between the sham and the real stimulation 
conditions. Before the visual stimulation began, participants 
had the subjective sickness scale (see Section C. Study design) 
explained to them and were instructed to report every time 
that their symptom severity changed. They were then told to 
put on the HMD and to not move their heads while the stimuli 
lasted. Once they were ready, the VR stimuli started. Every 
time participants reported a change in their symptom severity 
a note of the time was recorded. Once participants reported 
moderate symptoms, the HMD was removed from their heads, 
at which point the recovery period started which would last 
until they reported being back at “1” in terms of symptom 
severity. Note that each participant was given a 30-min break 
from the moment the first test session ended to ensure an 
equal resting period for subjects while keeping a heightened 
susceptibility state [22]. After the break the real stimulation 
started, and then the second test session was carried out. 
C. Study Design 
We used a double-blinded and 2×2×3 mixed-subject 
study design, which was modelled after Arshad et. al.’ work 
[21]. Data were both collected and analysed in an 
anonymized manner. The between-subjects condition is the 
type of tDCS stimulation (cathodal or anodal). While the 
hypothesis is based around cathodal stimulation, having an 
anodal condition permits the exclusion of the possibility of 
nonspecific tDCS effects. The first within-subjects variable is 
the timing of VR exposure (before or after active tDCS, as 
shown in Figure 1A). The second within-subjects variable is 
the sickness scenario (slight symptoms onset (SSO)/moderate 
symptoms onset (MSO)/recovery, as shown in Figure 1B). 
The SSO refers to the moment where participants experience 
any slight CS symptoms, the MSO being the point at which 
participants report moderate symptoms, which leads to the 
end of VR exposure. Lastly, Recovery is the point at which 
participants report the disappearance of their symptoms after 
VR exposure is terminated. Here, the severity of their 
symptoms was collected using subjective verbal report where 
1 = “no symptoms”, 2 = “slight symptoms”, 3 = “moderate 
symptoms” (This subjective scale is adapted from Arshad et. 
al.’s work [21]). The experimental hypothesis was that the 
timing of VR exposure would interact with sickness scenario 
in the cathodal stimulation group in the form of an increased 
time for SSO and MSO, and reduced recovery time between 
the before and after stimulation conditions. This difference 
should be exclusive to the cathodal group, and therefore not 
be present in anodal stimulation. 
D. Statistical Analysis 
All statistical analyses were done using SPSS 19.0 with a 
0.05 alpha level. The Greenhouse–Geisser correction was 
used when assumptions of sphericity were not met. 
 
1) Exploring the feasibility of tDCS.  
To examine the feasibility of cathodal tDCS in mitigating 
CS, we focused on comparisons of time on the three sickness 
scenarios in cathodal group. This analysis involved a repeated 
measures ANOVA with two within-subject factors: timing of 
 
Fig 1. Experimental procedure. A) Group and session design of the study; B) Procedure for each testing session. 
 
VR stimulus exposure (before and after cathodal tDCS) and 
sickness scenarios (SSO/MSO/Recovery).  
 
2) Exploring the specificity of tDCS.  
To examine the specificity of cathodal tDCS, we also 
focused on the comparison of time on the three sickness 
scenarios in the anodal group. Similarly, this analysis 
involved a repeated measures ANOVA with two within-
subject factors: timing of VR stimulus exlosure (before and 
after anodal tDCS) and sickness scenarios 
(SSO/MSO/Recovery).   
 
3) Exploring the polarity-dependent effect.  
To examine the polarity-dependent effect, we further 
analyzed the tDCS-related differences between the cathodal 
and anodal groups. This involved a mixed ANOVA with a 
between-subject factor (cathodal and anodal) and a within-
subject factor (normalized time on the three sickness 
scenarios, quantified as shown in Equation 1). 
 
   Normalized time=
𝑡𝑖𝑚𝑒𝑎𝑓𝑡𝑒𝑟−𝑡𝑖𝑚𝑒𝑏𝑒𝑓𝑜𝑟𝑒
𝑡𝑖𝑚𝑒𝑏𝑒𝑓𝑜𝑟𝑒
× 100%,      
(1) 
 time ∈ {SSO, MSO, Recovery}                   
 
E. tDCS and VR Stimulus 
tDCS was delivered by a battery-driven, constant current 
stimulator (NeuroConn, Germany) via a pair of rubber 
electrodes (35cm2) with conductive paste. A constant current 
of 1.5 mA intensity was delivered for 15 min (30-sec ramp up 
and 30-sec ramp down). The active stimulation (anodal or 
cathodal) electrode was placed on the left parietal cortex (at 
P3 of the 10/20 system; see Fig. 2) and the reference electrode 
was located on the ipsilateral shoulder on the deltoid muscle. 
For sham stimulation, the electrodes were placed at the same 
positions as active stimulation, but the stimulator was turned 
off after a 30-sec ramp up and ramp down period. Since the 
onset of tDCS often generates a tingling or itching sensation 
over the first minute of the stimulation, this sham procedure 
blinded the participants from differentiating between active 
and sham conditions. 
 
 
Fig 2. The active tDCS electrode placed on the left parietal cortex (at P3 
according to international electroencephalography (EEG) 10/20 system 
which is an internationally recognised method that allows EEG electrode 
placement to be standardised [24]). 
 
Given that the vestibular sensory organs, otoliths and 
semi-circular canals are sensitive to linear (e.g., gravity) and 
angular (e.g., rotation) acceleration stimuli respectively [6], 
[13], the nature of the VR stimuli is an outdoor rollercoaster 
application which aimed to induce at least two kinds of 
visual-vestibular sensory mismatch through virtual linear and 
angular acceleration: 1) visual-otoliths mismatch; 2) visual-
semi-circular canals mismatch. Here, the virtual linear and 
angular acceleration was achieved by changing the speed of 
rotations and movements of participant’s point of view. 
Specifically, the participants’ point of view is a camera that 
follows a programmable route that is created by placing a 
number of “waypoints” in the virtual space. When the camera 
passes through any of these waypoints, they can execute code 
that changes the rotation of the camera, the speed of these 
rotations, or the speed of movement of the camera through 
the route.  The final version of the route (see Fig 3) was 
developed through testing several participants in pilot 
studies. Even though the route is restarted after roughly 1 
minute, the nature of the rotations leads to changes in the 
direction of the camera, making each lap slightly different 
than the rest thus avoiding predictability. This VR stimuli was 
developed by Unity 3D version 2017.3 as well as its terrain-
making tool. The presentation delivery device was the Oculus 
Rift Development Kit 2.  
 
III. RESULTS 
A. tDCS safety and Sham condition 
None of the participants reported adverse effects from 
tDCS stimulation apart from slight tingling sensations. 
Participants’ accuracy rate for identifying the sham condition 
when given a choice between the two sessions was roughly at 
chance-level (50%) and every participant described it as “a 
guess”. This suggests that the sham condition was a success 
and participants could not differentiate it from active 
stimulation.  
B. The feasibility of tDCS on mitigating CS 
First of all, by using boxplots of the raw data, the datasets 
of one participant in Onset scenario and three participants in 
Recovery scenario were removed, according to the mild and 
extreme outliers. Also, one participant forgot to report in 
Onset scenario.  
For the remaining datasets, we found a main effect of test 
session (F(1, 6) = 9.507, p =0.022) and sickness scenario (F(2, 
12) = 8.520, p = 0.022), but there was no test session × 
sickness scenario interaction (F(2, 12) = 1.021, p = 0.390). 
Although further paired t-test shows that there was a 
significant difference in Recovery between test session 1 and 
2, it is contrary to our hypothesis, with the Recovery in test 
session 2 (M=29.333 sec, SD=4.553 sec) being significantly 
longer than that in test session 1 (M=12.609 sec, SD=3.396 
sec, as shown in Fig. 4A (t(6)=-3.988, p=0.007)). A possible 
 
Fig 3. The route followed by the camera. The yellow dots are the points at 
which code is executed to change the rotation of the camera, the speed of 




reasoning behind this phenomenon might be that participants 
experienced more CS symptoms than those in test session 1, 
so needed more time to recover (note that the same trend was 
obtained with the anodal group as shown in Fig. 4B). For the 
time of VR exposure, although the median time after tDCS 
was reduced, there was no significant difference with 
p=0.181 for SSO and p=0.282 for MSO. These results reveal 
that the tDCS mitigation protocol modelled after Arshad et. 
al.’s work [21] were not confirmed for HMD-VR-induced CS. 
C. The specificity of tDCS on mitigating CS 
Similarly, by using boxplots of the raw data, the datasets 
of three participants in SSO scenario and four participants in 
Recovery scenario were removed, according to the mild and 
extreme outliers. For the remaining datasets, we found a main 
effect of sickness scenario (F(2, 10) = 16.078, p = 0.001), but 
there was no significant main effect of test session (F(1, 5) = 
0.084, p =0.784) and test session × sickness scenario 
interaction (F(2, 10) = 0.362, p = 0.581). As shown in Fig. 
3B, further paired t-test shows that the mean value of SSO 
(M=54.639 sec, SD=17.853 for before Anodal and 
M=44.040, SD=12.267 for after Anodal) and MSO was 
reduced (M=172.836 sec, SD=33.650 for before Anodal and 
M=172.731, SD=18.029 for after Anodal), but no statistical 
significance (t(6)=1.193, p=0.278 for SSO and t(9)=0.004, 
p=0.997 for MSO). Regarding the mean value of Recovery, 
an increasing trend can be seen with M=24.885 sec and 
SD=4.889 for before Anodal and M=34.662 sec and 
SD=4.470 for after Anodal, respectively. These results reveal 
that anodal tDCS at left parietal cortex was unable to mitigate 
CS. 
 
Fig 5. The polarity-dependent tDCS differences in CS. *p<0.05. 
 
D. Exploring the polarity-dependent tDCS effect  
For anodal group, according to mild and extreme outliers 
in boxplots, the normalized datasets of two participants in 
SSO, one participant in MSO and Recovery respectively were 
removed. Similarly, for the cathodal group, one participant in 
MSO scenario was removed.  
Based on the remaining datasets, the mixed ANOVA 
shows a significant main effect of stimulation type (F(1, 7) = 
6.430, p =0.039), sickness scenarios (F(2, 14) = 6.958, p 
=0.025) and a trend towards significant stimulation type × 
sickness scenarios interaction (F(2, 14) = 5.271, p =0.051). 
Further paired t-test shows that there is a significant 
difference in SSO scenario (t(7)=2.460, p=0.041) between 
cathodal (M=225.495 sec, SD=89.335 sec) and anodal group 
(M=-2.490 sec, SD=13.245 sec, as shown in Fig 5). These 
results reveal that the cathodal tDCS indeed somehow 
delayed the onset of slight symptoms if compared to that in 
anodal condition. However, there are no significant 
differences in delaying the onset of moderate symptoms and 
reducing time to recovery between the two stimulation types.  
IV. DISCUSSION 
Based on the between-subject analysis, the presented 
findings reveal that cathodal tDCS delayed the onset of slight 
CS symptoms if compared to anodal tDCS, suggesting 
cathodal tDCS's inhibitory effect on vestibular cortical 
excitability. However, this inhibitory effect was not observed 
in delaying moderate symptoms and reducing the time to 
recovery. More importantly, we did not find this inhibitory 
effect using within-subject analysis, which is the fundamental 
difference between the current work and that of Arshad and 
colleagues [21]. The results suggest that Arshad's tDCS 
approach may not be strong enough to inhibit vestibular 
cortical activities during cybersickness, or may be ineffective 
due to inhibiting the vestibular cortex alone. Here, we discuss 
possible reasons for these findings in the context of stimuli 
approaches and tDCS procedure. 
A. Stimuli Approaches 
Arshad and colleagues [21] adopted traditional OAVR as 
their stimuli approach to induce MS. Since their speed of 
rotation was constant, and the direction of rotation was fixed 
(rightwards), their MS was purely induced by the visual-
otoliths mismatch. However, in current work, we are using 
rollercoaster as the stimuli which was designed to induce both 
visual-otolith and visual-semi-circular canals mismatch; thus, 
we surmise that our magnitude of sensory mismatch was 
higher than Arshad’s case. In this context, the same current 
intensity (1.5mA) and dose (15 min) were possibly not 
sufficient.  
 




Therefore, on the one hand, future studies can be planned 
with better optimized tDCS parameters. On the other hand, to 
provide more objective measures of participants internal state, 
physiological signals or advanced neuroimaging technologies 
can be used to verify the differences in the induced magnitude 
of sensory mismatch. 
B. tDCS Procedure 
We finished tDCS immediately prior to CS induction, but 
Arshad et. al.’s work [21] carried out tDCS during MS 
induction. That is, we were actually investigating the 
aftereffect of tDCS, while they focused on the online effect. 
Based on the self-reported severity of CS, our within-subject 
results did not show any statistically significant differences 
in the aftereffect on CS. However, in a recent study about 
GVS, the authors found an encouraging aftereffect on CS, 
although it was as short as 3 minutes, based on every 3-
minute post-GVS observation [15]. This may indicate that the 
suppression on vestibular sensory organs is more effective 
than that on vestibular cortical areas. 
The reason that we did not use tDCS during CS induction 
is that  cognitive activities during tDCS may interfere with or 
abolish tDCS effects [25]. Specifically, as mentioned earlier, 
vection is a trigger of CS. Previous research has found that 
the determinant of vection perception is attention [26], which 
is a fundamental capability for perception and cognition [27]. 
Therefore, the perception of vection is a kind of attention-
demanding cognitive activity so that CS induction during 
tDCS may indeed affect the tDCS effect according to [25]. In 
addition, from the perspective of user experience, asking 
participants to simultaneously wear VR-HMD and tDCS 
device was difficult due to the large size of tDCS sponge 
electrodes (35 cm2 area in current study instead of 25 cm2 in 
Arshad et. al.’s work [21]).  
Therefore, on the one hand, it is worthy to comply with 
[22]’s suggestion and study how to maintain the aftereffect of 
tDCS longer. On the other hand, given the success of Arshad 
et. al.’ work [21], future study should be done with smaller 
electrodes-based tDCS to explore the online impact of tDCS 
on VR-HMD-induced CS. Particularly, an interesting 
research question is that is it possible that the tDCS during 
CS induction to some extent can distract brain attentional 
network so that the awareness of vection is reduced and CS 
is mitigated? 
V. LIMITATION AND CONCLUSION 
This study did not use objective measurements (such as 
physiological data or postural data [28]) to assess the 
mitigation effect of tDCS, therefore we might miss finding a 
statistically significant and technically quantizable mitigation 
effect. Thus, a multimodal objective measurement can be 
planned for future study. This is especially pertinent given the 
progress on AI-based physiological feature learning for VR 
application [29] and highly-integrated research-grade [30] or 
commercial [31] VR-biosensing platforms.  
Also, given that cognitive activities during tDCS may 
interfere or abolish tDCS effects, a potential limitation for 
tDCS-based CS mitigations is that they are perhaps not suited 
to real-life VR applications, where the users have to perform 
cognitive activities. However, it is indeed an option for 
prophylactic treatment which can be implemented prior to 
experience VR scenes. 
Overall, based on between-subject analysis, we indeed 
found the delayed onset of slight CS symptoms, suggesting 
the possible inhibitory effect following cathodal tDCS. 
However, this inhibitory effect was not observed in the other 
two sickness scenarios, MSO and Recovery. Regarding the 
within-subject analysis, we did not find any subjective 
measurements-based significant results that could validate 
our hypothesis that cathodal tDCS stimulation over left 
parietal cortex would mitigate cybersickness. 
 
References 
  [1] G. G. Robertson, S. K. Card, and J. D. Mackinlay, ‘Three views of 
virtual reality: nonimmersive virtual reality’, Computer, vol. 26, no. 2, 
pp. 81-, Feb. 1993, doi: 10.1109/2.192002. 
[2] S. M. Slobounov, W. Ray, B. Johnson, E. Slobounov, and K. M. 
Newell, ‘Modulation of cortical activity in 2D versus 3D virtual reality 
environments: An EEG study’, Int. J. Psychophysiol., vol. 95, no. 3, 
pp. 254–260, Mar. 2015, doi: 10.1016/j.ijpsycho.2014.11.003. 
[3] J. O. Bailey and J. N. Bailenson, ‘Immersive Virtual Reality and the 
Developing Child’, in Cognitive Development in Digital Contexts, 
Elsevier, 2017, pp. 181–200. 
[4] F. Schmäl, ‘Neuronal Mechanisms and the Treatment of Motion 
Sickness’, Pharmacology, vol. 91, no. 3–4, pp. 229–241, 2013, doi: 
10.1159/000350185. 
[5] A. Sugiura, K. Tanaka, H. Takada, and M. Miyao, ‘Effect of 
Difference in Information Between Vision and Vestibular Labyrinth 
on a Human Body’, in Universal Access in Human–Computer 
Interaction. Designing Novel Interactions, vol. 10278, M. Antona and 
C. Stephanidis, Eds. Cham: Springer International Publishing, 2017, 
pp. 187–198. 
[6] M. Gallagher and E. R. Ferrè, ‘Cybersickness: a Multisensory 
Integration Perspective’, Multisensory Res., vol. 31, no. 7, pp. 645–
674, 2018, doi: 10.1163/22134808-20181293. 
[7] J. T. Reason, ‘Motion sickness—some theoretical considerations’, Int. 
J. Man-Mach. Stud., vol. 1, no. 1, pp. 21–38, Jan. 1969, doi: 
10.1016/S0020-7373(69)80009-X. 
[8] S. Weech and N. F. Troje, ‘Vection Latency Is Reduced by Bone-
Conducted Vibration and Noisy Galvanic Vestibular Stimulation’, 
Multisensory Res., vol. 30, no. 1, pp. 65–90, 2017, doi: 
10.1163/22134808-00002545. 
[9] B. Keshavarz and H. Hecht, ‘Validating an Efficient Method to 
Quantify Motion Sickness’, Hum. Factors J. Hum. Factors Ergon. 
Soc., vol. 53, no. 4, pp. 415–426, Aug. 2011, doi: 
10.1177/0018720811403736. 
[10] W. G. Wright, ‘Using virtual reality to augment perception, enhance 
sensorimotor adaptation, and change our minds’, Front. Syst. 
Neurosci., vol. 8, Apr. 2014, doi: 10.3389/fnsys.2014.00056. 
[11] Y.-H. Cha, ‘Mal de Debarquement’, Semin. Neurol., vol. 29, no. 05, 
pp. 520–527, Nov. 2009, doi: 10.1055/s-0029-1241038. 
[12] N. Takeuchi, T. Mori, Y. Suzukamo, and S.-I. Izumi, ‘Modulation of 
Excitability in the Temporoparietal Junction Relieves Virtual Reality 
Sickness’, Cyberpsychology Behav. Soc. Netw., vol. 21, no. 6, pp. 381–
387, Jun. 2018, doi: 10.1089/cyber.2017.0499. 
[13] K. E. Cullen, ‘Vestibular processing during natural self-motion: 
implications for perception and action’, Nat. Rev. Neurosci., vol. 20, 
no. 6, pp. 346–363, Jun. 2019, doi: 10.1038/s41583-019-0153-1. 
[14] S. M. Frank and M. W. Greenlee, ‘The parieto-insular vestibular cortex 
in humans: more than a single area?’, J. Neurophysiol., vol. 120, no. 3, 
pp. 1438–1450, Sep. 2018, doi: 10.1152/jn.00907.2017. 
[15] S. Weech, T. Wall, and M. Barnett-Cowan, ‘Reduction of 
cybersickness during and immediately following noisy galvanic 
vestibular stimulation’, Exp. Brain Res., vol. 238, no. 2, pp. 427–437, 
Feb. 2020, doi: 10.1007/s00221-019-05718-5. 
[16] M. A. Nitsche and W. Paulus, ‘Excitability changes induced in the 
human motor cortex by weak transcranial direct current stimulation’, 
J. Physiol., vol. 527, no. 3, pp. 633–639, Sep. 2000, doi: 
10.1111/j.1469-7793.2000.t01-1-00633.x. 
[17] N. Lang et al., ‘How does transcranial DC stimulation of the primary 
motor cortex alter regional neuronal activity in the human brain?: 
tDCS-induced changes of rCBF’, Eur. J. Neurosci., vol. 22, no. 2, pp. 
495–504, Jul. 2005, doi: 10.1111/j.1460-9568.2005.04233.x. 
[18] M. A. Nitsche et al., ‘Transcranial direct current stimulation: State of 
the art 2008’, Brain Stimulat., vol. 1, no. 3, pp. 206–223, Jul. 2008, 
doi: 10.1016/j.brs.2008.06.004. 
[19] W.-Y. Hsu, T. P. Zanto, J. A. Anguera, Y.-Y. Lin, and A. Gazzaley, 
‘Delayed enhancement of multitasking performance: Effects of anodal 
transcranial direct current stimulation on the prefrontal cortex’, Cortex, 
vol. 69, pp. 175–185, Aug. 2015, doi: 10.1016/j.cortex.2015.05.014. 
[20] A. Kyriakareli, S. Cousins, V. E. Pettorossi, and A. M. Bronstein, 
‘Effect of transcranial direct current stimulation on vestibular-ocular 
and vestibulo-perceptual thresholds’:, NeuroReport, vol. 24, no. 14, 
pp. 808–812, Oct. 2013, doi: 10.1097/WNR.0b013e3283646e65. 
[21] Q. Arshad et al., ‘Electrocortical therapy for motion sickness’, 
Neurology, vol. 85, no. 14, pp. 1257–1259, Oct. 2015, doi: 
10.1212/WNL.0000000000001989. 
[22] J. F. Golding, ‘Motion sickness susceptibility questionnaire revised 
and its relationship to other forms of sickness’, Brain Res. Bull., vol. 
47, no. 5, pp. 507–516, Nov. 1998, doi: 10.1016/S0361-
9230(98)00091-4. 
[23] M. McGill and S. A. Brewster, ‘I Am The Passenger: Challenges in 
Supporting AR/VR HMDs In-Motion’, in Proceedings of the 9th 
International Conference on Automotive User Interfaces and 
Interactive Vehicular Applications Adjunct - AutomotiveUI ’17, 
Oldenburg, Germany, 2017, pp. 251–251, doi: 
10.1145/3131726.3131876. 
[24] ‘10/20 System Positioning Manual’, 2012. http://chgd.umich.edu/wp-
content/uploads/2014/06/10-20_system_positioning.pdf. 
[25] J. C. Horvath, O. Carter, and J. D. Forte, ‘Transcranial direct current 
stimulation: five important issues we aren’t discussing (but probably 
should be)’, Front. Syst. Neurosci., vol. 8, 2014, doi: 
10.3389/fnsys.2014.00002. 
[26] T. Seno, H. Ito, and S. Sunaga, ‘The object and background hypothesis 
for vection’, Vision Res., vol. 49, no. 24, pp. 2973–2982, Dec. 2009, 
doi: 10.1016/j.visres.2009.09.017. 
[27] A. Gazzaley and L. D. Rosen, The distracted mind: ancient brains in 
a high-tech world. Cambridge, MA: MIT Press, 2016. 
[28] A. Koohestani et al., ‘A Knowledge Discovery in Motion Sickness: A 
Comprehensive Literature Review’, IEEE Access, vol. 7, pp. 85755–
85770, 2019, doi: 10.1109/ACCESS.2019.2922993. 
[29] G. Li and M. Adeel Khan, ‘Deep Learning on VR-Induced Attention’, 
in 2019 IEEE International Conference on Artificial Intelligence and 
Virtual Reality (AIVR), San Diego, CA, USA, Dec. 2019, pp. 163–
1633, doi: 10.1109/AIVR46125.2019.00033. 
[30] G. Li, S. Zhou, Z. Kong, and M. Guo, ‘Closed-Loop Attention 
Restoration Theory for Virtual Reality-Based Attentional Engagement 
Enhancement’, Sensors, vol. 20, no. 8, p. 2208, Apr. 2020, doi: 
10.3390/s20082208. 
[31] L. Looxid, ‘VR Neurofeedback: A New Drug-free Treatment for 
Mental Disorders.’, VR Neurofeedback: A New Drug-free Treatment 
for Mental Disorders, Jan. 03, 2018. https://arvrjourney.com/vr-
neurofeedback-a-new-drug-free-treatment-for-mental-disorders-
f721f652f159 (accessed Jul. 27, 2020). 
 
 
 
